Skip to content

ARRAY BIOPHARMA INC

CIK 0001100412

← back to feed
Revenue (TTM)
$171.61M
−46.6% YoY Q3 Apr 2019
Net Income (TTM)
−$96.52M
−129.5% YoY Q3 Apr 2019
EPS Diluted (TTM)
−$0.45
−127.3% YoY Q3 Apr 2019
Gross Margin
70.5%
Q3 Apr 2019
Operating Margin
-54.6%
Q3 Apr 2019
Net Margin
-56.2%
Q3 Apr 2019
Free Cash Flow (TTM)
−$70.31M
Q3 Apr 2019
Cash
$96.64M
Q3 Apr 2019
Total Debt
$134.25M
Q3 Apr 2019
Shares Outstanding
221.75M sh
Q3 Apr 2019

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings